Latest News for: eosinophilic

Edit

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)

Hastings Tribune 20 Aug 2025
Study met primary endpoint demonstrating barzolvolimab’s ...
Edit

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) (Form 8-K) (Celldex Therapeutics Inc)

Public Technologies 19 Aug 2025
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) · Study met primary endpoint demonstrating barzolvolimab's ability to potently deplete mast cells in the gastrointestinal tract.
Edit

Eosinophilic Esophagitis Pipeline Outlook Report 2025: Key 25+ Companies and Breakthrough Therapies Shaping the Future Landscape

GetNews 13 Aug 2025
Inactive Products Eosinophilic Esophagitis Key Companies Eosinophilic Esophagitis Key Products Eosinophilic Esophagitis- Unmet Needs Eosinophilic Esophagitis- Market Drivers and Barriers Eosinophilic ...
Edit

TSLP plays a key role in the development of eosinophilic esophagitis

Famagusta Gazette 12 Aug 2025
In a study published in the journal Allergy, the team found that a protein called TSLP plays a key role in the development of eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus ... ■ ....
Edit

Hypereosinophilic Syndrome Pipeline Insight 2025: Pioneering Precision Approaches to Tame Eosinophilic Overactivity | DelveInsight

GetNews 21 Jul 2025
Hypereosinophilic Syndrome (HES) is a rare group of disorders characterized by persistently elevated eosinophil levels, often leading to end-organ damage affecting the heart, lungs, skin, and nervous system.
Edit

Aqilion finalizes the eosinophilic esophagitis specific formulation pharmacokinetic study with the drug candidate AQ280

Pharmiweb 21 Jul 2025
Aqilion finalizes the eosinophilic esophagitis specific formulation pharmacokinetic study with the drug candidate AQ280 ... Eosinophilic Esophagitis is an allergic disease of the esophagus.
Edit

Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis

Nasdaq Globe Newswire 08 Jul 2025
Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis ... .
Edit

Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis (Form 6-K) (Eupraxia Pharmaceuticals Inc)

Public Technologies 08 Jul 2025
The primary objective is to assess the efficacy of EP-104GI in improving tissue health, as measured by the Eosinophilic Esophagitis Histology Scoring System ("EoEHSS").
Edit

Eosinophilic Esophagitis Treatment Market Size in the 7MM was ~USD 1,800 million in the 2023, ...

GetNews 24 Jun 2025
Eosinophilic Esophagitis Current Marketed and Eosinophilic Esophagitis Emerging Therapies Eosinophilic Esophagitis Market Dynamics. Eosinophilic Esophagitis market drivers and Eosinophilic Esophagitis ...
Edit

Eosinophilic Esophagitis Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, ...

GetNews 24 Jun 2025
"Eosinophilic Esophagitis Market" ... Some of the key facts of the Eosinophilic Esophagitis Market Report ... Eosinophilic Esophagitis current marketed and Eosinophilic Esophagitis emerging therapies Eosinophilic Esophagitis Market Dynamics.
Edit

Eosinophilic Disorder Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, ...

GetNews 29 May 2025
"Eosinophilic Disorder Treatment Market" ... Other forms include Eosinophilic Gastroenteritis, Eosinophilic Colitis, Hypereosinophilic Syndrome (HES), and Eosinophilic Asthma, each defined by the affected organ system and severity.
Edit

Global Eosinophilic Esophagitis Market Poised for Unprecedented Growth, Projected to Skyrocket to USD 2,032.8 Billion by 2033, Reveals Future Market Insights

Pharmiweb 28 May 2025
The global eosinophilic esophagitis market is on the cusp of a remarkable transformation, according to the latest comprehensive analysis released by Future Market Insights (FMI) ... Eosinophilic ...
  • 1

Article Search

tools
×
×
×
×